WITHDRAWN—a resource for withdrawn and discontinued drugs
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
Post-marketing drug withdrawals can be associated with various events, ranging from safety issues such as reported deaths or severe side-effects, to a multitude of non-safety problems including lack of efficacy, manufacturing, regulatory or business issues. During the last century, the majority of drugs voluntarily withdrawn from the market or prohibited by regulatory agencies was reported to be related to adverse drug reactions. Understanding the underlying mechanisms of toxicity is of utmost importance for current and future drug discovery. Here, we present WITHDRAWN, a resource for withdrawn and discontinued drugs publicly accessible at http://cheminfo.charite.de/withdrawn. Today, the database comprises 578 withdrawn or discontinued drugs, their structures, important physico-chemical properties, protein targets and relevant signaling pathways. A special focus of the database lies on the drugs withdrawn due to adverse reactions and toxic effects. For approximately one half of the drugs in the database, safety issues were identified as the main reason for withdrawal. Withdrawal reasons were extracted from the literature and manually classified into toxicity types representing adverse effects on different organs. A special feature of the database is the presence of multiple search options which will allow systematic analyses of withdrawn drugs and their mechanisms of toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common toxicity types associated with drug withdrawals in the United States and Europe are hepatic (21%), cardiovascular (16%), hematological (11%), neurological (9%), and carcinogenicity (8%) (Figure 2) (20).”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0720s76 · Cited by 3,705 · cited 1×
“Furthermore, the information on biological pathways and SNPs, including amino acid changes, peptide positions, MAFs, PolyPhen scores (37) and links to dbSNP, were added in the detailed record of a target.”
BackgroundData, information, knowledge and principle: back to metabolism in KEGG
Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,092
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
An Algorithm for Subgraph Isomorphism
Ullmann, J. R. (1976) · Journal of the ACM · doi:10.1145/321921.321925 · Cited by 2,277
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
UniProt Knowledgebase: a hub of integrated protein data
Magrane, M., & Consortium, U. (2011) · Database · doi:10.1093/database/bar009 · Cited by 1,463
Cited by
Items 301–321 of 321
Mantiri, V. A. D., Tendean, L. E. N., & Turalaki, G. L. A. (2026) · JURNAL BIOS LOGOS · doi:10.35799/jbl.v15i3.66648
Méthodes computationnelles pour améliorer les phases primaires de recherche de nouveaux médicaments
Grignard, J. (2022) · theses.fr (ABES) · doi:10.70675/14300afaz228fz45bcz939fz8f8eab3c6699
Definitions, Principles, and Concepts of Pharmacoepidemiology and Pharmacovigilance
Chinzowu, T., & Nishtala, P. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26472-6.00047-4
Burgers, E. J., Sharma, R. P., Danilyuk, T. Y., Vogel, S., Wijaya, L. S., Leist, M., Zickgraf, F. M., Schildknecht, S., Bouwman, P., van de Water, B., et al. (2026) · Toxicology · doi:10.1016/j.tox.2026.154483
GPCR Drug Development from Preclinical Insights to Clinical Applications
Patel, V., Chauhan, M., Nair, A., Patel, K. P., Tiwari, P., Kadiri, S. K., & Kaundal, B. (2026) · Springer eBooks · doi:10.1007/978-981-95-9081-0_15
Sosa, A. M., Prieto, M. J., & Martinez, C. S. (2026) · Springer eBooks · doi:10.1007/978-981-92-0038-2_12
Colombo, M. V., Borgström, A., & Filippi, B. G. H. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2683592
Artificial Intelligence for Toxicity Prediction: A Comprehensive Review
Grover, C., & Manhas, S. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.44s.120
Liver Disease and Plant‐Derived Phytoconstituents: From Ethnopharmacology to Modern Medicine
Pandey, B., Kharel, S., Shrestha, A., Sapkota, B., Subedi, L., & Panta, S. (2026) · Phytotherapy Research · doi:10.1002/ptr.70383
Deep metadata annotations and FAIR enhancement of DrugMatrix in vitro bioassay data
Ross, N. C., Jagodnik, K. M., Oprea, T. I., & Schürer, S. C. (2026) · Scientific Data · doi:10.1038/s41597-026-07570-z
Niu, J., Wagner, S., Preißner, R., & Banerjee, P. (2026) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2026.2704958
Murthy, M. K. (2026) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2026.111921
FAIRsharing record for: WITHDRAWN: A Resource for Withdrawn and Discontinued Drugs
FAIRsharing Team (2018) · FAIRsharing.org · doi:10.25504/fairsharing.otyqfw
Çiçek, B. (2025) · Marmara University Open Access System
Generative Synthetic Data Models for Pre-Clinical Drug Discovery
HU, B. (2026) · UWSpace (University of Waterloo)
Metadata
- Authors
- Siramshetty, V. B., Nickel, J., Omieczynski, C., Gohlke, B.-O., Drwal, M. N., & Preissner, R.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Corresponding author
- Drwal, Malgorzata N.
- Preissner, Robert
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-08
- Volume
- 44
- Issue
- D1
- Pages
- D1080-D1086
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702851
- OpenAlex
- W2147670638
- Cited by
- 286
- References
- 45
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 35 · 2023: 36 · 2022: 27 · 2021: 28 · 2020: 37 · 2019: 24 · 2018: 30 · 2017: 12 · 2016: 12 · 2015: 1
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by-nc)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- drug withdrawal, adverse drug reactions, drug toxicity, toxicity mechanisms, drug safety, drug discovery, chemical databases, protein targets, signaling pathways, physicochemical properties
- MeSH terms
- Pharmaceutical Preparations, Humans, Proteins, Signal Transduction, Internet, Polymorphism, Single Nucleotide, Drug Recalls, Safety-Based Drug Withdrawals, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.